TACSTD2 and squamous cell carcinoma of penis: The result of Kaplan-Meier survival analysis revealed that elevated expression of TROP-2 correlates with reduced overall survival (OS) and 5-year disease-free survival (DFS) in PSCC patients (p < 0.05) (Fig. 2A).